Consortium Bio-Technologies Private Limited
About Consortium Bio-Technologies Private Limited
Data last updated:
Consortium Bio-Technologies Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the collection agencies segment of the business services sector. It was incorporated on 19 December 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24129DL1996PTC083937. Its GSTIN is 07AABCC2028E1Z9 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinay K Bali and Siddhant Bali.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 158 1st Floor Punjabi Bagh Apartment Madipur, New Delhi, Delhi, India – 110063.
As per the financials filed for FY 2019, the company reported a revenue of ₹1.31 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹59,535 (net margin 0.5%) and EBITDA of ₹2.34 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years.
As per MCA filings, the company has open charges of ₹7 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Consortium Bio-Technologies Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address158 1st Floor Punjabi Bagh Apartment Madipur, New Delhi, Delhi, India – 110063
- IndustryBusiness Services, Collection Agencies, Packaging Activities, Organising Conventions, Office Administration, Call Centers
To see the full contact details of Consortium Bio-Technologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Consortium Bio-Technologies is information and communication. In detail, this covers wired, wireless or satellite telecommunication activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J5 | Wired, wireless or satellite Telecommunication activities |
To see the full business activity and turnover split of Consortium Bio-Technologies Private Limited, buy the company report.
Financials of Consortium Bio-Technologies Private Limited
FY 2019 filings availableConsortium Bio-Technologies Private Limited reported revenue of ₹1.31 Cr (up 8% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 37% over three years, including 8% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹59,535 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Consortium Bio-Technologies Private Limited, buy the company report.
Board of directors of Consortium Bio-Technologies Private Limited
Consortium Bio-Technologies has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddhant Bali Also directs: Smart Steps Outsourcing & Placement Private Limited | Additional Director | 16 May 2023 | 3 Years 5 Months | Current |
| Vinay K Bali | Director | 01 Apr 1998 | 28 Years 7 Months | Current |
Peer comparison
Consortium Bio-Technologies Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wired, wireless or satellite telecommunication activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ramedias Technologies Private Limited | ₹1.33 Cr (FY 2019) | 332090.0% | Thanjavur, Tamil Nadu, India | |||
| Fasutonetto Services Private Limited | ₹1.32 Cr (FY 2025) | 167.0% | Ghaziabad, Uttar Pradesh, India | |||
| Live Fibernet Service Private Limited | ₹1.32 Cr (FY 2024) | 22.0% | Tirupur, Tamil Nadu, India | |||
| VSN Telecommunications Private Limited | ₹1.32 Cr (FY 2023) | -57.0% | New Delhi, Delhi, India | |||
| Meded Meetings Private Limited | ₹1.32 Cr (FY 2025) | -8.0% | Hyderabad, Telangana, India | |||
| Consortium Bio-Technologies Private Limitedthis company | ₹1.31 Cr (FY 2019) | ₹59,535 | 0.5% | 8.0% | New Delhi, Delhi, India | |
| Buro Business Private Limited | ₹1.3 Cr (FY 2024) | 133.0% | Kolkata, West Bengal, India | |||
| RV Infotainment Private Limited | ₹1.3 Cr (FY 2024) | -37.0% | Bangalore, Karnataka, India | |||
| Sis Networks Private Limited | ₹1.3 Cr (FY 2025) | -13.0% | Delhi, India | |||
| Karnataka Tele Electronics Private Limited | ₹1.29 Cr (FY 2025) | 2.0% | Bangalore, Karnataka, India | |||
| Adri Infocom Private Limited | ₹1.27 Cr (FY 2025) | -11.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Consortium Bio-Technologies Private Limited, buy the company report.
Auditor
Consortium Bio-Technologies Private Limited is audited by Charanjeet Malhotra for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Charanjeet Malhotra | FY 2017 | 083001 |
Shareholding
The shareholding of Consortium Bio-Technologies Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Consortium Bio-Technologies Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Feb 1998 | 90053260 | State Bank of India | ₹7 Lakh | Open |
To see the full charge records of Consortium Bio-Technologies Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Consortium Bio-Technologies Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Disposed |
To see the full case history of Consortium Bio-Technologies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Consortium Bio-Technologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Consortium Bio-Technologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCC2028E1Z9 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Consortium Bio-Technologies Private Limited, buy the company report.
Recent activity
Consortium Bio-Technologies Private Limited has 5 board changes on record since 1998: 2 appointments and 3 cessations. The latest: Siddhant Bali was appointed as Additional Director on 16 May 2023.
Frequently asked questions
Consortium Bio-Technologies is an active private limited company based in New Delhi, Delhi, India. The company works in collection agencies, within the business services industry. It was incorporated on 19 December 1996 (30+ years old) and is registered under CIN U24129DL1996PTC083937.
Consortium Bio-Technologies has 2 current directors:
- Siddhant Bali - Additional Director
- Vinay K Bali - Director
The latest financial statements of Consortium Bio-Technologies on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Consortium Bio-Technologies is 07AABCC2028E1Z9, registered in Delhi.
The CIN (Corporate Identification Number) of Consortium Bio-Technologies is U24129DL1996PTC083937. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Consortium Bio-Technologies has 1 court case on record: 1 filed against it.
Consortium Bio-Technologies was incorporated on 19 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Consortium Bio-Technologies by revenue are Ramedias Technologies Private Limited, Fasutonetto Services Private Limited, Live Fibernet Service Private Limited, VSN Telecommunications Private Limited, Meded Meetings Private Limited and 5 more, all in the same principal business activity (wired, wireless or satellite telecommunication activities).
Siddhant Bali was appointed as Additional Director on 16 May 2023. Chander Bali Kanta ceased to be Additional Director on 18 Apr 2023. Shiv Prakash Bali ceased to be Additional Director on 23 Apr 2016. Consortium Bio-Technologies has 5 board changes on record in total.
The registered office of Consortium Bio-Technologies is at 158 1st Floor Punjabi Bagh Apartment Madipur, New Delhi, Delhi, India – 110063.
Consortium Bio-Technologies operates in the business services industry, in the collection agencies segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
